verapamil has been researched along with atrial natriuretic factor in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (38.71) | 18.7374 |
| 1990's | 17 (54.84) | 18.2507 |
| 2000's | 2 (6.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angermann, CE; Dominiak, P; Gerzer, R; Kemkes, BM; Spes, CH; Stempfle, HU; Theisen, K; Weil, J | 1 |
| Donckier, J; Galanti, L; Hanet, C; Ketelslegers, JM; Pouleur, H; Robert, A; Stoleru, L; Van Mechelen, H | 1 |
| Abaterusso, C; Brocco, E; Carraro, A; Cipollina, MR; Fioretto, P; Frigato, F; Muollo, B; Riva, F; Trevisan, M; Velussi, M | 1 |
| Buckley, JW; Cubeddu, LX; Hedner, T; Masotto, C; Negro-Villar, A; Posvar, E | 1 |
| Catto-Smith, AG; Gall, DG; Hardin, JA; O'Loughlin, EV; Patrick, MK | 1 |
| Amadio, L; Antonicelli, R; Galletti, P; Gambini, C; Marini, M; Paciaroni, E; Tomassini, PF | 1 |
| Böhm, RO; Mooij, JM; Rahn, KH; Schiffers, PM; Struyker Boudier, HA; Van Bortel, LM | 1 |
| Lembke, JM; Saelens, DA; Zawada, ET | 1 |
| Eiskjaer, H; Jespersen, B; Pedersen, EB; Rasmussen, LM | 2 |
| Doubell, AF | 1 |
| Ernst, JE; Gerzer, R; Haufe, MC; Heim, JM; Theisen, K; Weil, J | 1 |
| Ernst, JE; Gerzer, R; Haufe, MC; Theisen, K; Weil, J | 1 |
| Breuhaus, BA; Chimoskey, JE; Hastings, DA; Holzman, MD; Otero, HO; Saneii, HH; Sparks, HV; Wangler, RD | 1 |
| Dawson, AP; Hill, CE; Olson, MS; Pryor, JS | 1 |
| Barrio, V; de Arriba, G; López-Novoa, JM; Olivera, A; Rodriguez-Puyol, D | 1 |
| Ganz, MB; Pekar, SK; Perfetto, MC; Sterzel, RB | 1 |
| Bauer, C; Della Bruna, R; Kurtz, A; Pfeilschifter, J | 1 |
| Baranowska, B; Cantin, M; Genest, J; Gutkowska, J; Talbot, P | 1 |
| Bergey, JL; Kotler, D | 1 |
| Arriba, G; Caramelo, C; Lamas, S; López-Novoa, JM; Olivera, A; Rodriguez-Barbero, A; Rodriguez-Puyol, D; Schrier, RW | 1 |
| Bagnis, C; Bitker, MO; Deray, G; Dubois, M; Jacobs, C; Jacquiaud, C | 1 |
| Lasova, LS; Mutafova-Yambolieva, VN; Venkova, KM | 1 |
| Abe, A; Karaki, H | 1 |
| Claycomb, WC; Dresdner, KP; Field, LJ; Kline, RP; Lanson, NA; Sorota, S; Steinhelper, ME; Wit, AL | 1 |
| Foresta, C; Mioni, R | 1 |
| Argenzio, RA; Armstrong, M | 1 |
| Ezra, D; Peleg, E; Rosenthal, T; Shamiss, A | 1 |
| Aardal, S; Helle, KB; Lillestłl, IK | 1 |
| Iversen, BM; Myking, O; Ofstad, J; Svarstad, E | 1 |
| Lerch, R; Montessuit, C; Papageorgiou, I; Rosenblatt-Velin, N | 1 |
4 trial(s) available for verapamil and atrial natriuretic factor
| Article | Year |
|---|---|
Comparative effects of verapamil and volume overload on atrial natriuretic factors and the renin-angiotensin aldosterone-vasopressin system.
Topics: Adult; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Male; Plasma Substitutes; Plasma Volume; Renin-Angiotensin System; Verapamil | 1992 |
Age-related antihypertensive and haemodynamic effects of verapamil SR: clinical results and effects on atrial natriuretic peptide.
Topics: Age Factors; Aged; Atrial Natriuretic Factor; Blood Pressure; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Time Factors; Verapamil | 1990 |
The influence of chronic treatment with verapamil on plasma atrial natriuretic peptide levels in young and elderly hypertensive patients.
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Double-Blind Method; Humans; Hypertension; Middle Aged; Time Factors; Verapamil | 1990 |
The role of atrial natriuretic peptide in the diuretic effect of Ca2+ entry blockers.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Calcium Channel Blockers; Diuretics; Felodipine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuresis; Nifedipine; Renin; Renin-Angiotensin System; Verapamil | 1993 |
27 other study(ies) available for verapamil and atrial natriuretic factor
| Article | Year |
|---|---|
Effects of graded exercise on blood pressure, heart rate, and plasma hormones in cardiac transplant recipients before and during antihypertensive therapy.
Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Drug Therapy, Combination; Enalapril; Epinephrine; Exercise Test; Female; Follow-Up Studies; Furosemide; Heart Rate; Heart Transplantation; Hormones; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Postoperative Complications; Renin; Verapamil | 1992 |
Low-dose endothelin-1 potentiates volume-induced secretion of atrial natriuretic factor.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Volume; Cardiovascular System; Catecholamines; Dogs; Dose-Response Relationship, Drug; Endothelins; Heart; Heart Atria; Pressure; Verapamil | 1992 |
Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Calcium Channel Blockers; Cilazapril; Diabetes Mellitus, Type 1; Female; Humans; Hypertension; Male; Nifedipine; Sodium Chloride; Verapamil | 1992 |
The effect of atrial natriuretic peptide on intestinal electrolyte transport.
Topics: Animals; Atrial Natriuretic Factor; Biological Transport, Active; Calcium; Chlorides; Cyclic GMP; Electrolytes; Female; Histamine; Histamine Antagonists; Ileum; Intestine, Small; Jejunum; Kidney; Peptide Fragments; Potassium; Rats; Sodium; Verapamil; Water | 1991 |
Influence of calcium infusion on plasma atrial natriuretic peptide in conscious dogs: intervention with calcium antagonist, verapamil.
Topics: Acute Disease; Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium Chloride; Dogs; Female; Heart Rate; Hypercalcemia; Verapamil | 1990 |
Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Circadian Rhythm; Creatinine; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension, Renal; Kidney Function Tests; Lipoproteins; Male; Middle Aged; Verapamil | 1989 |
The effect of calcium antagonists on atrial natriuretic peptide (ANP) release from the rat heart during rapid cardiac pacing.
Topics: Animals; Atrial Natriuretic Factor; Calcium Channel Blockers; Cardiac Pacing, Artificial; Heart; Heart Rate; Kinetics; Male; Nifedipine; Perfusion; Rats; Rats, Inbred Strains; Verapamil | 1989 |
[Hemodynamic and medicamentous modification of stimulated atrial natriuretic factor secretion].
Topics: Adult; Aged; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Disease; Cyclic GMP; Female; Humans; Male; Middle Aged; Molsidomine; Verapamil | 1989 |
Verapamil impairs secretion of stimulated atrial natriuretic factor in humans.
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Coronary Disease; Cyclic GMP; Female; Heart Atria; Humans; Male; Middle Aged; Verapamil | 1988 |
Coronary vasoconstrictor effects of atriopeptin II.
Topics: Adenosine; Animals; Atrial Natriuretic Factor; Coronary Circulation; Dose-Response Relationship, Drug; Guinea Pigs; Norepinephrine; Perfusion; Regional Blood Flow; Vasoconstriction; Verapamil | 1985 |
Potassium-mediated stimulation of hepatic glycogenolysis.
Topics: Animals; Atrial Natriuretic Factor; Atropine; Egtazic Acid; In Vitro Techniques; Indomethacin; Kinetics; Liver; Liver Glycogen; Masoprocol; Nifedipine; Nitroprusside; Perfusion; Phentolamine; Potassium; Propranolol; Rats; Verapamil | 1987 |
Atrial natriuretic peptide inhibits angiotensin II-induced contraction of isolated glomeruli and cultured glomerular mesangial cells of rats: the role of calcium.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cells, Cultured; Gallic Acid; Glomerular Mesangium; In Vitro Techniques; Kidney Glomerulus; Rats; Rats, Inbred Strains; Verapamil | 1988 |
Sustained release verapamil in renal hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Delayed-Action Preparations; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Verapamil | 1988 |
Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Benzofurans; Calcium; Calcium Channel Blockers; Cell Division; Cells, Cultured; DNA; Drug Synergism; Fluorescent Dyes; Fura-2; Gallic Acid; Glomerular Mesangium; Insulin; Male; Rats; Spectrometry, Fluorescence; Tetradecanoylphorbol Acetate; Verapamil | 1988 |
Effect of synthetic atrial natriuretic peptide on rat renal juxtaglomerular cells.
Topics: Animals; Atrial Natriuretic Factor; Calcium; Cyclic AMP; Cyclic GMP; Diuretics; In Vitro Techniques; Juxtaglomerular Apparatus; Peptide Fragments; Rats; Renin; Verapamil | 1986 |
Plasma immunoreactive atrial natriuretic factor is inhibited by selective blockade of alpha 2-adrenergic receptors in conscious Sprague-Dawley rats.
Topics: Animals; Atrial Natriuretic Factor; Calcium; Clonidine; Drug Interactions; Female; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Opioid; Verapamil; Yohimbine | 1987 |
Effects of atriopeptins I, II and III on atrial contractility, sinus nodal rate (guinea pig) and agonist-induced tension in rabbit aortic strips.
Topics: Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Calcimycin; Diuretics; In Vitro Techniques; Male; Muscle Contraction; Muscle Proteins; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Nitroprusside; Rabbits; Sinoatrial Node; Verapamil | 1985 |
Effect of atrial natriuretic peptide and calcium antagonists on platelet-activating factor-induced contraction and intracellular calcium mobilization in rat mesangial cells.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Calcium; Calcium Channel Blockers; Cells, Cultured; Diterpenes; Dose-Response Relationship, Drug; Fura-2; Furans; Gallic Acid; Ginkgolides; Glomerular Mesangium; Hydrogen-Ion Concentration; Lactones; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Rats, Wistar; Spectrometry, Fluorescence; Verapamil | 1994 |
Prevention of acute cyclosporin nephrotoxicity by verapamil and atrial natriuretic factor in the rat.
Topics: Animals; Atrial Natriuretic Factor; Cyclosporine; Glomerular Filtration Rate; Kidney; Male; Perfusion; Rats; Rats, Sprague-Dawley; Renal Circulation; Vascular Resistance; Verapamil | 1994 |
Atrial natriuretic peptide inhibits the purinergic and not the adrenergic component of electrically induced contractile responses in guinea pig vas deferens.
Topics: Adenosine Triphosphate; Adrenergic Antagonists; Animals; Atrial Natriuretic Factor; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Naloxone; Neurotransmitter Agents; Nitrendipine; Phenylephrine; Prazosin; Receptors, Adrenergic; Receptors, Purinergic; Vas Deferens; Verapamil; Yohimbine | 1993 |
Synergistic effects of cyclic AMP-related vasodilators and the phosphatase inhibitor okadaic acid.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Bucladesine; Colforsin; Drug Synergism; Ethers, Cyclic; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Nitroglycerin; Nitroprusside; Okadaic Acid; Phosphoprotein Phosphatases; Potassium; Rats; Rats, Wistar; Vasodilator Agents; Verapamil | 1993 |
Spontaneous activity in transgenic mouse heart: comparison of primary atrial tumor with cultured AT-1 atrial myocytes.
Topics: Acetylcholine; Action Potentials; Animals; Antigens, Polyomavirus Transforming; Atrial Natriuretic Factor; Benzazepines; Calcium Channels; Carbachol; Cardiovascular Agents; Cell Communication; Cell Division; GTP-Binding Proteins; Heart; Heart Atria; Heart Neoplasms; Membrane Potentials; Mice; Mice, Inbred DBA; Mice, Transgenic; Myocardium; Potassium; Tumor Cells, Cultured; Verapamil | 1993 |
The role of calcium ions in rat Leydig cell steroidogenesis induced by atrial natriuretic peptide.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Calcium; Calcium Channels; Cells, Cultured; Chorionic Gonadotropin; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Drug Synergism; Gonadotropin-Releasing Hormone; Leydig Cells; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Testosterone; Time Factors; Verapamil | 1993 |
ANP inhibits NaCl absorption and elicits Cl secretion in porcine colon: evidence for cGMP and Ca mediation.
Topics: Absorption; Amiloride; Animals; Atrial Natriuretic Factor; Biological Transport; Calcium; Chlorides; Colon; Cyclic GMP; Electrophysiology; Ions; Sodium Chloride; Swine; Tetrodotoxin; Verapamil | 1993 |
Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Isradipine; Milrinone; Muscle, Smooth, Vascular; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Rolipram; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilation; Verapamil; Vinca Alkaloids | 1998 |
Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
Topics: Adult; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Captopril; Enalapril; Exercise; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Circulation; Renal Plasma Flow, Effective; Verapamil | 2002 |
Insulin resistance in adult cardiomyocytes undergoing dedifferentiation: role of GLUT4 expression and translocation.
Topics: Animals; Atrial Natriuretic Factor; Biological Transport, Active; Calcium Channel Blockers; Cell Differentiation; Cell Size; Cells, Cultured; Deoxyglucose; Diacetyl; Enzyme Activation; Gene Expression Regulation; Glucose Transporter Type 1; Glucose Transporter Type 4; Insulin; Insulin Resistance; Monosaccharide Transport Proteins; Muscle Proteins; Myocardial Contraction; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-cbl; Rats; RNA, Messenger; Sarcolemma; Ubiquitin-Protein Ligases; Verapamil | 2004 |